Get started
RocketTickers

Ionis Report PositiveData from Phase2 Study of AKCEA-APO(a)-LRx

Long
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)  
RocketTickers  
NASDAQ:IONS   Ionis Pharmaceuticals, Inc.
Beyond Technical Analysis
2
0
beyondta
IONS: Ionis Pharmaceuticals, Inc.
2018-09-24 07:00:00
Akcea and Ionis Report Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.